These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21525722)

  • 21. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
    Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP
    Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG; Fischer BM; Pappot H
    Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
    Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25 Dihydroxyvitamin D(3) receptor expression in superficial transitional cell carcinoma of the bladder: a possible prognostic factor?
    Sahin MO; Canda AE; Yorukoglu K; Mungan MU; Sade M; Kirkali Z
    Eur Urol; 2005 Jan; 47(1):52-7. PubMed ID: 15582249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder.
    Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T
    Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer.
    Oka N; Yamamoto Y; Takahashi M; Nishitani M; Kanayama HO; Kagawa S
    BJU Int; 2005 Mar; 95(4):660-3. PubMed ID: 15705099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
    Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
    Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
    Hu X; Ruan Y; Cheng F; Yu W; Zhang X; Larré S
    Int J Urol; 2011 Sep; 18(9):630-7. PubMed ID: 21672035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
    Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
    Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
    J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
    Wang KJ; Li H; Wei Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.
    Lebret T; Watson RW; Molinié V; O'Neill A; Gabriel C; Fitzpatrick JM; Botto H
    Cancer; 2003 Sep; 98(5):970-7. PubMed ID: 12942564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.